The invention is concerned with the use of lycopene, optionally in combination with vitamin E and/or C or other biologically active ingredients as disclosed in the specification, in the manufacture of a composition for the primary and secondary prevention of angiogenesis-associated pathologies and coadjuvant treatment thereof; as well as with particular novel formulations comprising lycopene.
本发明涉及
番茄红素(可选择与
维生素 E 和/或 C 或说明书中公开的其他
生物活性成分结合使用)在制造用于血管生成相关病症的一级和二级预防及其辅助治疗的组合物中的用途;以及包含
番茄红素的特定新型制剂。